Epoprostenol

FDA Approved: * June 27, 2008
Pharm Company: * GENERAMEDIX
Category: Blood Pressure

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator. When used as a drug, it is also known as epoprostenol.[1] The terms are sometimes used interchangeably.[2] Contents 1 Function 2 Medical uses 3 Degradation 4 Mechanism 5 Members[10] 6 Pharmacology 7 Synthesis 7.1 Biosynthesis 7.2 Artificial synthesis ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Diluent Intravenous Solution
NDC: 0173-0518
Labeler:
Glaxosmithkline LLC
Diluent 1 ml/Ml Intravenous Solution
NDC: 0173-0857
Labeler:
Glaxosmithkline LLC
Epoprostenol Sodium .5 mg/1 Intravenous Injection, Powder, for Solution
NDC: 0703-1985
Labeler:
Teva Parenteral Medicines, Inc.
Epoprostenol Sodium 1.5 mg/1 Intravenous Injection, Powder, for Solution
NDC: 0703-1995
Labeler:
Teva Parenteral Medicines, Inc.
Epoprostenol .5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 62756-059
Labeler:
Sun Pharmaceutical Industries Limited
Epoprostenol 1.5 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 62756-060
Labeler:
Sun Pharmaceutical Industries Limited

Related Brands

Drugs with the same active ingredients